Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
Abstract Canine cognitive dysfunction (CCD) is common in aged dogs and has many similarities with Alzheimer’s disease. Unfortunately, like Alzheimer’s disease, CCD cannot be cured. In the present study, we treated dogs with CCD with our newly developed and characterized butyrylcholinesterase inhibit...
Guardado en:
Autores principales: | Maja Zakošek Pipan, Sonja Prpar Mihevc, Malan Štrbenc, Urban Košak, Ilija German Ilić, Jurij Trontelj, Simon Žakelj, Stanislav Gobec, Darja Pavlin, Gregor Majdič |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32c976e38cff4eb89133a4590bc3ef91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Benzoylcholine, Indole-3-acetic And Human Serum Butyrylcholinesterase Interactions
por: Ebru Bodur,, et al.
Publicado: (2006) -
Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes.
por: André Brooking Negrão, et al.
Publicado: (2013) -
Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase
por: Tena Čadež, et al.
Publicado: (2021) -
Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma
por: Maja Brloznik, et al.
Publicado: (2021) -
Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response
por: Zivkovic AR, et al.
Publicado: (2016)